X-13594910-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_015507.4(EGFL6):c.262G>A(p.Gly88Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000315 in 1,206,000 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000045 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000030 ( 0 hom. 13 hem. )
Consequence
EGFL6
NM_015507.4 missense
NM_015507.4 missense
Scores
8
7
2
Clinical Significance
Conservation
PhyloP100: 9.68
Genes affected
EGFL6 (HGNC:3235): (EGF like domain multiple 6) This gene encodes a member of the epidermal growth factor (EGF) repeat superfamily. Members of this superfamily are characterized by the presence of EGF-like repeats and are often involved in the regulation of cell cycle, proliferation, and developmental processes. The gene product contains a signal peptide, suggesting that it is secreted; an EGF repeat region consisting of 4 complete EGF-like repeats and 1 partial EGF-like repeat, 3 of which have a calcium-binding consensus sequence; an arg-gly-asp integrin association motif; and a MAM domain, which is believed to have an adhesive function. This gene is expressed early during development, and its expression has been detected in lung and meningioma tumors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGFL6 | NM_015507.4 | c.262G>A | p.Gly88Arg | missense_variant | 3/12 | ENST00000361306.6 | |
EGFL6 | NM_001167890.2 | c.262G>A | p.Gly88Arg | missense_variant | 3/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGFL6 | ENST00000361306.6 | c.262G>A | p.Gly88Arg | missense_variant | 3/12 | 1 | NM_015507.4 | A2 | |
EGFL6 | ENST00000380602.3 | c.262G>A | p.Gly88Arg | missense_variant | 3/12 | 1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111721Hom.: 0 Cov.: 23 AF XY: 0.0000590 AC XY: 2AN XY: 33889
GnomAD3 genomes
AF:
AC:
5
AN:
111721
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33889
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 182242Hom.: 0 AF XY: 0.0000299 AC XY: 2AN XY: 66778
GnomAD3 exomes
AF:
AC:
3
AN:
182242
Hom.:
AF XY:
AC XY:
2
AN XY:
66778
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000302 AC: 33AN: 1094279Hom.: 0 Cov.: 28 AF XY: 0.0000361 AC XY: 13AN XY: 359791
GnomAD4 exome
AF:
AC:
33
AN:
1094279
Hom.:
Cov.:
28
AF XY:
AC XY:
13
AN XY:
359791
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000448 AC: 5AN: 111721Hom.: 0 Cov.: 23 AF XY: 0.0000590 AC XY: 2AN XY: 33889
GnomAD4 genome
AF:
AC:
5
AN:
111721
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
33889
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.262G>A (p.G88R) alteration is located in exon 3 (coding exon 3) of the EGFL6 gene. This alteration results from a G to A substitution at nucleotide position 262, causing the glycine (G) at amino acid position 88 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Loss of ubiquitination at K89 (P = 0.0334);Loss of ubiquitination at K89 (P = 0.0334);
MVP
MPC
0.96
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at